Holen Sie sich die Stockscreener-App
1.57
0.63%
-0.01
Handel nachbörslich:
1.68
0.11
+7.01%
Schlusskurs vom Vortag:
$1.58
Offen:
$1.6
24-Stunden-Volumen:
204.21K
Relative Volume:
0.14
Marktkapitalisierung:
$8.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-2.1308
EPS:
-0.7368
Netto-Cashflow:
-
1W Leistung:
-8.19%
1M Leistung:
-77.94%
6M Leistung:
-83.94%
1J Leistung:
-88.62%
1-Tages-Spanne:
$1.51
$1.61
1-Wochen-Bereich:
$1.51
$1.74
52-Wochen-Spanne:
$1.51
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.57 | 8.83M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-10-09 | Eingeleitet | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Is Calidi Biotherapeutics Inc. stock a falling knife or bargain buyJuly 2025 Selloffs & Weekly Setup with ROI Potential - khodrobank.com
Analyzing net buyer seller activity in Calidi Biotherapeutics Inc.Forecast Cut & AI Enhanced Trade Execution Alerts - Newser
Real time social sentiment graph for Calidi Biotherapeutics Inc.2025 Stock Rankings & Real-Time Chart Pattern Alerts - Newser
Calidi Biotherapeutics Inc. stock chart pattern explainedNew Guidance & Capital Efficiency Focused Strategies - Newser
Jobs Data: Is Calidi Biotherapeutics Inc. trading at a discountJobs Report & Weekly Setup with High ROI Potential - khodrobank.com
How high can Calidi Biotherapeutics Inc. stock goQuarterly Trade Report & Trade Opportunity Analysis Reports - Newser
Using economic indicators to assess Calidi Biotherapeutics Inc. potentialJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Chart based analysis of Calidi Biotherapeutics Inc. trendsJuly 2025 WrapUp & Fast Gain Stock Tips - Newser
Calidi Biotherapeutics Inc. stock prediction for this week2025 Volume Leaders & Weekly Momentum Picks - Newser
Will earnings trigger a reversal in Calidi Biotherapeutics Inc.Market Trend Review & Technical Buy Zone Confirmations - Newser
How to read the order book for Calidi Biotherapeutics Inc.Risk Management & Weekly High Conviction Ideas - Newser
Is Calidi Biotherapeutics Inc. reversing from oversold territoryWeekly Market Report & Reliable Price Breakout Alerts - Newser
What institutional flow reveals about Calidi Biotherapeutics Inc.Stock Surge & Stock Portfolio Risk Control - Newser
Calidi Biotherapeutics Inc. Stock Poised for Technical Comeback2025 Trade Ideas & Long-Term Growth Portfolio Plans - beatles.ru
Will Calidi Biotherapeutics Inc. stock recover after earningsWeekly Profit Report & Free Community Consensus Stock Picks - khodrobank.com
What to do if you’re stuck in Calidi Biotherapeutics Inc.July 2025 Institutional & Momentum Based Trading Ideas - Newser
Calidi Biotherapeutics to Showcase RedTail Platform at H.C. Wainwright Global Investment Conference - citybuzz -
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Calidi Biotherapeutics to present at H.C. Wainwright Global Investment Conference. - AInvest
Revolutionary Cancer Gene Therapy: Calidi Bio to Present RedTail Platform for Metastatic Treatment - Stock Titan
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Florida Times-Union
Can Calidi Biotherapeutics Inc. navigate macro headwinds2025 Trading Volume Trends & Accurate Buy Signal Notifications - khodrobank.com
How cyclical is Calidi Biotherapeutics Inc.’s revenue streamJuly 2025 Institutional & High Accuracy Swing Entry Alerts - khodrobank.com
What does recent volatility data suggest for Calidi Biotherapeutics Inc.July 2025 Opening Moves & Stock Market Timing Techniques - Newser
Understanding Calidi Biotherapeutics Inc.’s price movementWeekly Loss Report & Weekly High Return Forecasts - Newser
Is Calidi Biotherapeutics Inc. building a consolidation base2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
Will earnings trigger a reversal in Calidi Biotherapeutics Inc2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
Candlestick signals on Calidi Biotherapeutics Inc. stock todayJuly 2025 Institutional & Accurate Technical Buy Alerts - Newser
Real time scanner hits for Calidi Biotherapeutics Inc. explainedWeekly Profit Report & Fast Moving Stock Watchlists - Newser
Should I average down on Calidi Biotherapeutics Inc. stockJuly 2025 Trends & Consistent Profit Trading Strategies - sundaytimes.kr
Has Calidi Biotherapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - Newser
Is a relief rally coming for Calidi Biotherapeutics Inc. holdersJuly 2025 Sentiment & Stock Market Timing Techniques - Newser
What’s next for Calidi Biotherapeutics Inc. stock priceJuly 2025 Volume & Free Community Consensus Stock Picks - Newser
Using portfolio simulators with Calidi Biotherapeutics Inc. includedJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
Combining machine learning predictions for Calidi Biotherapeutics Inc.July 2025 Intraday Action & Daily Volume Surge Signals - Newser
Calidi Biotherapeutics Updates Presentation Disclosure - TipRanks
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
Kapitalisierung:
|
Volumen (24h):